Literature DB >> 12464558

Phenotypic differences in murine chondrocyte cell lines derived from mature articular cartilage.

H M van Beuningen1, R Stoop, P Buma, N Takahashi, P M van der Kraan, W B van den Berg.   

Abstract

OBJECTIVE: To obtain well characterized immortalized murine chondrocyte cell lines. The cell lines were obtained from mature articular chondrocytes, instead of embryonal cells which are used in most other studies.
METHODS: Pieces of articular cartilage were cut from murine patellae and femoral heads. Chondrocytes were isolated by digestion with collagenase. These cells were cultured in monolayer and immortalized by transfection of the SV40 large T antigen gene. To preserve the differentiated phenotype, the resulting clones were cultured in three-dimensional carriers, alginate beads. The phenotypes of the cells were characterized using the following parameters: Cell morphology (light microscopy), messenger RNA (RT-PCR) and protein (immunohistochemistry) levels of extracellular matrix molecules. Moreover, responsiveness to interleukin-1(IL-1) was determined by measuring production of proteoglycans ((35)S-sulfate incorporation) and of nitric oxide (Griess reaction).
RESULTS: Sixteen clones were obtained, ten (P1 to P10) derived from patellar cartilage, and six (H1 to H6) from femoral head cartilage. In seven cell lines (P2, P5, H1, H3, H4, H5, H6) high production of type II collagen corresponded with high levels of mRNA of type II collagen (and prevalence of the IIB type) and with high IL-1-induced suppression of proteoglycan synthesis. Like intact murine articular cartilage, all cell lines produced type I and type X collagens, but mRNA levels of both types of collagen were never higher in the cell lines as compared with intact cartilage.
CONCLUSION: Our results demonstrate that it is possible to immortalize mature murine articular chondrocytes. Each of the obtained chondrocyte cell lines appeared to have a stable phenotype. Both relatively differentiated and relatively dedifferentiated chondrocyte cell lines could be identified. Copyright 2002 OsteoArthritis Research Society International. Published by Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12464558     DOI: 10.1053/joca.2002.0855

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  5 in total

1.  Ginsenoside Rb1 inhibits matrix metalloproteinase 13 through down-regulating Notch signaling pathway in osteoarthritis.

Authors:  Wei Wang; Li Zeng; Ze-ming Wang; Sihan Zhang; Xiao-Feng Rong; Rong-Heng Li
Journal:  Exp Biol Med (Maywood)       Date:  2015-06-09

2.  Expression of TGF-β Signaling Regulator RBPMS (RNA-Binding Protein With Multiple Splicing) Is Regulated by IL-1β and TGF-β Superfamily Members, and Decreased in Aged and Osteoarthritic Cartilage.

Authors:  S Shanmugaapriya; A van Caam; L de Kroon; Elly L Vitters; B Walgreen; H van Beuningen; E Blaney Davidson; Peter M van der Kraan
Journal:  Cartilage       Date:  2016-02-24       Impact factor: 4.634

3.  Neural EGFL like 1 as a potential pro-chondrogenic, anti-inflammatory dual-functional disease-modifying osteoarthritis drug.

Authors:  Chenshuang Li; Zhong Zheng; Pin Ha; Wenlu Jiang; Emily A Berthiaume; Seungjun Lee; Zane Mills; Hsinchuan Pan; Eric C Chen; Jie Jiang; Cymbeline T Culiat; Xinli Zhang; Kang Ting; Chia Soo
Journal:  Biomaterials       Date:  2019-10-12       Impact factor: 12.479

Review 4.  The role of the Notch pathway in healthy and osteoarthritic articular cartilage: from experimental models to ex vivo studies.

Authors:  Nadia Sassi; Lilia Laadhar; Maha Driss; Meriam Kallel-Sellami; Slaheddine Sellami; Sondes Makni
Journal:  Arthritis Res Ther       Date:  2011-03-18       Impact factor: 5.156

5.  Catabolic and proinflammatory effects of leptin in chondrocytes are regulated by suppressor of cytokine signaling-3.

Authors:  Anna Koskinen-Kolasa; Katriina Vuolteenaho; Riku Korhonen; Teemu Moilanen; Eeva Moilanen
Journal:  Arthritis Res Ther       Date:  2016-10-03       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.